Viral vector-based vaccines against SARS-CoV-2

Viral vectors have been frequently applied for vaccine development. It has also been the case for vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to tackle the coronavirus disease 2019 (COVID-19) pandemic. A multitude of different viral vectors have been mainly targetin...

Full description

Bibliographic Details
Published in:Exploration of Immunology
Main Author: Kenneth Lundstrom
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2021-10-01
Subjects:
Online Access:https://www.explorationpub.com/Journals/ei/Article/100320